About the Authors
- Mary F. Kearney
-
* E-mail: kearneym@ncifcrf.gov
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Jonathan Spindler
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Wei Shao
-
Affiliation Advanced Biomedical Computing Center, SAIC, Frederick, Maryland, United States of America
- Sloane Yu
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Elizabeth M. Anderson
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Angeline O'Shea
-
Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH Bethesda, Maryland, United States of America
- Catherine Rehm
-
Affiliation Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH Bethesda, Maryland, United States of America
- Carry Poethke
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Nicholas Kovacs
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- John W. Mellors
-
Affiliation Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- John M. Coffin
-
Affiliation Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America
- Frank Maldarelli
-
Affiliation HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Competing Interests
John Mellors is a consultant for Gilead Sciences and owns share options in RFS Pharmaceuticals. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MFK JWM JMC FM. Performed the experiments: MFK JS SY. Analyzed the data: WS EMA NK. Contributed reagents/materials/analysis tools: MFK FM AOS CR CP. Wrote the paper: MFK JWM JMC FM.